A Randomized Trial of High‐ versus Low‐Dose Subcutaneous Interleukin‐2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
1997 • 2,989 citations
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 • 2,670 citations
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 • 1,912 citations
HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
1997 • 527 citations
Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study
1995 • 430 citations
Nonparametric Hypotheses and Rank Statistics for Unbalanced Factorial Designs
1997 • 209 citations
Application OF Branched DNA Signal Amplification to Monitor Human Immunodeficiency Virus Type 1 Burden in Human Plasma
1994 • 175 citations
Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons
1997 • 164 citations
1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections
1994 • 107 citations
Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay
1993 • 85 citations
Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.
1997 • 82 citations
Safety and Effects of Interleukin-2 Plus Zidovudine in Asymptomatic Individuals Infected with Human Immunodeficiency Virus
1991 • 71 citations
Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration.
1992 • 46 citations
A Phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudine
1994 • 32 citations
Pharmacokinetics and Pharmacodynamics of Subcutaneous Interleukin‐2 in HIV‐Infected Patients
1996 • 22 citations